Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Egeberg

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
The British Journal of Dermatology|September 11, 2017
The value and pitfalls of biologics registries for psoriasisA Egeberg, A Nast
The British Journal of Dermatology|July 5, 2018
Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitationsJ P Thyssen, A Egeberg
The British Journal of Dermatology|March 10, 2020
Do we need to fear methotrexate?J H Haugaard, A Egeberg
The British Journal of Dermatology|September 9, 2015
Does treatment with statins protect against psoriasis?A Egeberg, P Riis Hansen
The British Journal of Dermatology|July 27, 2019
Comparing apples, oranges and atopic dermatitisY M F Andersen, A Egeberg
The British Journal of Dermatology|July 31, 2019
Seborrhoeic dermatitis - understood or understudied?Y M F Andersen, A Egeberg
Journal of the European Academy of Dermatology and Venereology : JEADV|October 2, 2019
Use of topical calcipotriol for identification of patients with psoriasis in administrative healthcare data-a validation studyA Egeberg, Y M F Andersen
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2019
The many faces of rosacea: liberal diagnostic criteria have ramifications on disease prevalence and accuracyN Wienholtz, A Egeberg, J P Thyssen
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2017
Validation of psoriasis severity classification based on use of topical or systemic treatmentA Egeberg, M Gyldenløve, C Zachariae, et al.
The British Journal of Dermatology|February 16, 2020
Incidences of different cancer types in dermatomyositis, polymyositis and dermatopolymyositis: results of a registry analysisM Zidane, C Dressler, A Nast, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
The British Journal of Dermatology|September 11, 2017
The value and pitfalls of biologics registries for psoriasisA Egeberg, A Nast
The British Journal of Dermatology|July 5, 2018
Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitationsJ P Thyssen, A Egeberg
The British Journal of Dermatology|March 10, 2020
Do we need to fear methotrexate?J H Haugaard, A Egeberg
The British Journal of Dermatology|September 9, 2015
Does treatment with statins protect against psoriasis?A Egeberg, P Riis Hansen
The British Journal of Dermatology|July 27, 2019
Comparing apples, oranges and atopic dermatitisY M F Andersen, A Egeberg
The British Journal of Dermatology|July 31, 2019
Seborrhoeic dermatitis - understood or understudied?Y M F Andersen, A Egeberg
Journal of the European Academy of Dermatology and Venereology : JEADV|October 2, 2019
Use of topical calcipotriol for identification of patients with psoriasis in administrative healthcare data-a validation studyA Egeberg, Y M F Andersen
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2019
The many faces of rosacea: liberal diagnostic criteria have ramifications on disease prevalence and accuracyN Wienholtz, A Egeberg, J P Thyssen
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2017
Validation of psoriasis severity classification based on use of topical or systemic treatmentA Egeberg, M Gyldenløve, C Zachariae, et al.
The British Journal of Dermatology|February 16, 2020
Incidences of different cancer types in dermatomyositis, polymyositis and dermatopolymyositis: results of a registry analysisM Zidane, C Dressler, A Nast, et al.
Pageof 11